| For: | Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg 2009; 1(1): 38-48 [PMID: 21160794 DOI: 10.4240/wjgs.v1.i1.38] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v1/i1/38.htm |
| Number | Citing Articles |
| 1 |
Yuxin Lu, Sara Milchgrub, Gaurav Khatri, Purva Gopal. Metachronous Uterine Endometrioid Adenocarcinoma and Peritoneal Mesothelioma in Lynch Syndrome: A Case Report. International Journal of Surgical Pathology 2017; 25(3) doi: 10.1177/1066896916680745
|
| 2 |
C. Buffet. Conduite à tenir devant une ascite. EMC - Hépatologie 2012; 27(3) doi: 10.1016/S1155-1976(12)59731-7
|
| 3 |
|
| 4 |
Su Jin Lee, Mi Jung Park, Ok Geun Kim, Ji Geon Jang, Ju Ho Noh, Byoung Hwan Park, Jin Sook Lee. Case of Malignant Mesothelioma of the Peritoneum and Pleura. Korean Journal of Medicine 2014; 87(6) doi: 10.3904/kjm.2014.87.6.756
|
| 5 |
Thanh Thuy Phan, Thi Quynh Huong Pham, Van Duy Le, Thi Lan Tran, Van Chuong Tran, Nguyen Thị Hoa Mai, Thu Phuong Phan, Van Giap Vu. Malignant Mesothelioma Extending from Peritoneum to Pleura: A Diagnostic Challenge and Case Report. Case Reports in Oncology 2026; 19(1) doi: 10.1159/000551912
|
| 6 |
Aditi Bhatt, Loma Parikh, Suniti Mishra, Olivier Glehen. Pathology of Peritoneal Metastases. 2020; doi: 10.1007/978-981-15-3773-8_11
|
| 7 |
Simone A Jarrett, Brenda Chiang, Raul Hiedra, Richard S Kalman. A rare presentation of malignant peritoneal mesothelioma in a 22-year-old man. Journal of Case Reports and Images in Oncology 2022; 8 doi: 10.5348/100101Z10SJ2022CR
|
| 8 |
Wenjie Yin, Guoqi Zheng, Kunna Yang, Hui Song, Yufei Liang. Analysis of prognostic factors of patients with malignant peritoneal mesothelioma. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1350-5
|
| 9 |
Aatur D Singhi, Alyssa M Krasinskas, Haroon A Choudry, David L Bartlett, James F Pingpank, Herbert J Zeh, Alyssa Luvison, Kimberly Fuhrer, Nathan Bahary, Raja R Seethala, Sanja Dacic. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Modern Pathology 2016; 29(1) doi: 10.1038/modpathol.2015.121
|
| 10 |
Ana Mervic, Katja Goricar, Tanja Blagus, Alenka Franko, Katarina Trebusak-Podkrajsek, Metoda Dodic Fikfak, Vita Dolzan, Viljem Kovac. Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases. Radiology and Oncology 2024; 58(1) doi: 10.2478/raon-2024-0009
|
| 11 |
Qing-Qing Wang, Guo-Qi Zheng, Dong-Liang Yang, Yu-Fei Liang, Wen-Jie Yin, Shan-Shan Su. Pretreatment Controlling Nutritional Status Score and Lactate Dehydrogenase as Predictive Markers of Survival in Patients with Malignant Peritoneal Mesothelioma. Nutrition and Cancer 2018; 70(8) doi: 10.1080/01635581.2018.1560481
|
| 12 |
Li-ying Chen, Ling-xiu Huang, Jin Wang, Yi Qian, Li-zheng Fang. Malignant peritoneal mesothelioma presenting with persistent high fever. Journal of Zhejiang University SCIENCE B 2011; 12(5) doi: 10.1631/jzus.B1000338
|
| 13 |
Antonio Sommariva, Vittorina Zagonel, Carlo Riccardo Rossi. The Role of Laparoscopy in Peritoneal Surface Malignancies Selected for Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Annals of Surgical Oncology 2012; 19(12) doi: 10.1245/s10434-012-2465-5
|
| 14 |
Xiyong Fan, Chris McLaughlin, Cleo Robinson, Jason Ravasini, Karin Schelch, Thomas Johnson, Nico van Zandwijk, Glen Reid, Anthony M. George. Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma. FASEB BioAdvances 2019; 1(9) doi: 10.1096/fba.2019-00040
|
| 15 |
Yaofei Jiang, Zijie Mei, Hong Cao, Sirui Li, Haibo Xu, Hui Qiu, Yu Liu. Meningeal metastasis of a malignant peritoneal mesothelioma: A case report and literature review. Cancer Biology & Therapy 2019; 20(12) doi: 10.1080/15384047.2019.1647053
|
| 16 |
Jian Li, Jinhui Yang, Shuo Hu. Malignant Peritoneal Mesothelioma With Butterfly-Shaped Muscle Metastasis. Clinical Nuclear Medicine 2023; 48(4) doi: 10.1097/RLU.0000000000004575
|
| 17 |
Feihu Tang, Yong Cui, Yuan Gao. Diagnosis and treatment of malignant retroperitoneal mesothelioma: A case report. Medicine 2024; 103(17) doi: 10.1097/MD.0000000000037985
|
| 18 |
Bin Huang, Hongsheng Liu, Haiyan Zhou. Localized peritoneal epithelioid clear cell subtype mesothelioma: a case report and literature review. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1790964
|
| 19 |
Sonia Alavi, Azadeh Haeri, Iman Mahlooji, Simin Dadashzadeh. Tuning the Physicochemical Characteristics of Particle-Based Carriers for Intraperitoneal Local Chemotherapy. Pharmaceutical Research 2020; 37(6) doi: 10.1007/s11095-020-02818-8
|
| 20 |
Hideyuki Nishi, Naohisa Waki, Hiroshi Kawai, Shigeki Kinoshita, Masahiro Ishizaki, Masayuki Mano. Evaluation of Fatal Malignant Peritoneal Mesothelioma Cases in Japan. The Japanese Journal of Gastroenterological Surgery 2012; 45(5) doi: 10.5833/jjgs.45.475
|
| 21 |
Takanobu Iwadare, Takefumi Kimura, Yusuke Nagata, Hiroshi Suzuki, Hideo Kunimoto, Hiroyuki Kitabatake, Ayako Seki, Yasuhide Ochi, Etsuo Hara, Takeji Umemura. A case of malignant peritoneal mesothelioma with a Fitz-Hugh-Curtis syndrome-like imaging finding. Clinical Journal of Gastroenterology 2023; 16(3) doi: 10.1007/s12328-023-01770-5
|
| 22 |
|
| 23 |
Kirby R. Qin, Divyanshu Dua. Diagnostic Dilemma: Primary Peritoneal Mesothelioma With Para-Occupational Asbestos Exposure. Journal of Global Oncology 2017; 3(6) doi: 10.1200/JGO.2016.005280
|
| 24 |
Hiroaki Ikushima, Toshio Sakatani, Sayaka Ohara, Hideyuki Takeshima, Hajime Horiuchi, Teppei Morikawa, Kazuhiro Usui. Cisplatin plus pemetrexed therapy and subsequent immune checkpoint inhibitor administration for malignant peritoneal mesothelioma without pleural lesions. Medicine 2020; 99(22) doi: 10.1097/MD.0000000000019956
|
| 25 |
Puhao Li, Juan Liang, Yue Chen, Haoyuan Ding. 68Ga-FAPI PET/CT Depicted Non–FDG-Avid Malignant Peritoneal Mesothelioma. Clinical Nuclear Medicine 2025; 50(5) doi: 10.1097/RLU.0000000000005676
|
| 26 |
Wenjie Yin, Guoqi Zheng, Shanshan Su, Yufei Liang. The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma. Oncology Research and Treatment 2019; 42(6) doi: 10.1159/000499677
|
| 27 |
Shoubo Cao, Shi Jin, Jingyan Cao, Jing Shen, Jing Hu, Dehai Che, Bo Pan, Jiawen Zhang, Xiaoxi He, Dian Ding, Feifei Gu, Yan Yu. Advances in malignant peritoneal mesothelioma. International Journal of Colorectal Disease 2015; 30(1) doi: 10.1007/s00384-014-2029-1
|
| 28 |
|
| 29 |
Wen-jie Yin, Guo-qi Zheng, Yue-feng Chen, De-qiang Chen, Ning-ning Sun, Yu-xin Yang, Xin-yi Sun, Li-qing Kang. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis. La radiologia medica 2016; 121(4) doi: 10.1007/s11547-015-0609-y
|
| 30 |
Maho Konishi, Takahiro Kanyama, Kenichiro Maeno, Chiho Miyagawa, Sachiko Minamiguchi, Hiroki Katsushima, Toshihide Shimada. Detection of Anaplastic Lymphoma Kinase-Rearranged Mesothelioma Cells in Ascites by Companion Diagnostics. Acta Cytologica 2020; 64(4) doi: 10.1159/000503663
|
| 31 |
Leanne M. Brown, Sarah G. Wilkins, Varun V. Bansal, David G. Su, Jorge Gomez‐Mayorga, Kiran K. Turaga, Craig G. Gunderson, Byrne Lee, Garrett M. Nash, John L. Hays, Kanwal P. Raghav, Aliya L. Husain, Michael D. Kluger, Marjorie G. Zauderer, Hedy L. Kindler, H. Richard Alexander. Consensus guideline for the management of peritoneal mesothelioma. Cancer 2025; 131(13) doi: 10.1002/cncr.35868
|
| 32 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3) doi: 10.1016/j.cpsurg.2019.100727
|
| 33 |
Edoardo Virgilio, Paolo Mercantini, Mario Ferri, Marco Cavallini, Antonella Teggi, Vincenzo Ziparo.
Coexistence of Diffuse Malignant Peritoneal Mesothelioma and
Candida norvegensis
Peritonitis
. Surgical Infections 2014; 15(5) doi: 10.1089/sur.2014.088
|
| 34 |
XiaoChang Fang, Lin Shu, TianLiang Chen, XiaoLe Zhao, LiuCui Yang, Tingting Dou, Lijie Yang, Xuanfei Li, Maohui Feng. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-023-01901-z
|
| 35 |
Leanne M. Brown, Sarah G. Wilkins, Varun V. Bansal, David G. Su, Jorge Gomez-Mayorga, Kiran K. Turaga, Craig G. Gunderson, Byrne Lee, Garrett M. Nash, John L. Hays, Kanwal P. Raghav, Aliya L. Husain, Michael D. Kluger, Marjorie G. Zauderer, Hedy L. Kindler, H. Richard Alexander, Aaron Mansfield, Adam Khader, Ahmed Hamed, Alberto Marchevsky, Alda Tam, Alex Fisher, Alex Kim, Alexander Loftus, Alexander S. Thomas, Alexandra Gangi, Alicia Greene, Alissa Greenbaum, Amanda Arrington, Anai Kothari, Anand Govindarajan, Andrei Nikiforchin, Andres Abreu, Andrew Blakely, Andrew Churg, Andrew Łowy, Andrew M. Bellizzi, Andrew Nicholson, Ankit Dhiman, Anthony Villano, Antoine Bouchard-Fortier, Anwaar Saeed, Armando Sardi, Baylee Bakkila, Beatrice Sun, Benjamin Powers, Beth Helmink, Biren Reddy, Bradley White, Brian Sparkman, Caitlin Hester, Carla Harmath, Carlos Chan, Carrie Luu, Charles Staley, Chukwuemeka Ihemelandu, Colette Brottman, Colette Pameijer, Colin Court, Conor O’Neill, Dan Blazer, Daniel Abbott, Daniel Labow, Daniel Milgrom, Darryl Outlaw, Darryl Schuitevoerder, David B. Chapel, David Bartlett, David Hanna, David Ilson, Deepa Magge, Marcello Deraco, Devon Freudenberger, Deyali Chatterjee, Divya Sood, Edward Levine, Ekaterina Baron, Elizabeth Godfrey, Elizabeth Olecki, Emily Papai, Emmanuel Gabriel, Eric Pletcher, Erin P. Ward, Fabian Johnston, Felipe Lopez-Ramirez, Forest Mahoney, Francisco Izquierdo, Frederick A. Godley, Gary N. Mann, George Salti, Georgios Georgakis, Georgios Karagkounis, Gilbert Murimwa, Giorgos Karakousis, Hallbera Gudmundsdottir, Hanna Sanoff, Harveshp Mogal, Hunter Witmer, Ioannis Konstantinidis, Jackson Baril, Jacquelyne J. Gaddy, James Cusack Campbell, Jane Wang, Jason Foster, Jason L. Hornick, Javid Sadjadi, Jeff Sussman, Jeffrey M. Sutton, Jennifer Keller, Jeremy Sharib, Jesus Esquivel, Joanna Buchheit, Joel Baumgartner, John Miura, John Paul Shen, Jonathan B. Greer, Jonathan Dowell, Joseph Kim, Joshua Winer, Jula Veerapong, Kamran Idrees, Kevin Sullivan, Kimberly Kopecky, Konstantinos Chouliaras, Kostas Votanopoulos, Kristina A. Matkowskyj, Kurt Schultz, Laura Lambert, Lauren Raymond, Lauren Schleimer, Leopoldo Fernandez, Lindy Davis, Lloyd Mack, Lucian Chirieac, M. Talha Waheed, Madeline B. Torres, Maheswari Senthil, Marcovalerio Melis, Maria Russell, Mary Garland-Kledzik, Mason Vierra, Masoumeh Ghayouri, Matthew Gubens, Mazin Al-Kasspooles, Mecker Moller, Mehraneh D. Jafari, Melanie Ongchin, Melissa Taggart, Michael Foote, Michael Offin, Michael Wach, Mikaël Soucisse, Mohamed Adam, Mohammad Haroon Asif Choudry, Mohammed Suraju, Mojgan Hosseini, Monica Malec, Mustafa Raoof, Nabil Wasif, Nadège Fackche, Nader Hanna, Neal Bhutiani, Nelya Melnitchouk, Niraj J. Gusani, Oliver Eng, Olivier Glehen, Pathik Aravind, Patricio Polanco, Patrick Wagner, Paul Helft, Paul Sugarbaker, Pompiliu Piso, Prakash Pandalai, Rachel Kim, Rachyl Shanker, Raed Al-Rajabi, Raghav Sundar, Rajiv Agarwal, Randall Zuckerman, Rebecca Wiatrek, Ricardo Bello, Richard Attanoos, Richard Berri, Richard Hoehn, Richard Royal, Riom Kwakman, Rita Akumuo, Robert Barone, Robert Sticca, Rudy Lackner, Rupen Shah, Ryan Merkow, Sabha Ganai, Sam George Pappas, Samantha Ruff, Sameer Patel, Samer Naffouje, Samuel Butensky, Sanjay Bagaria, Sara Daniel, Scott Sherman, Sean Dineen, Seth J. Concors, Shannon Radomski, Sherif Abdel-Misih, Soo Ryum Yang, Stacey Cohen, Stephanie Greco, Steven Libutti, Susan Campbell, T. Clark Gamblin, Taylor Jaraczewski, Thinzar Lwin, Travis Grotz, Ugwuji Maduekwe, Umut Sarpel, Uqba Khan, Vignesh Vudatha, Wai Chin Foo, Wilbur B. Bowne, Xavier Keutgen, Xiang Gao, Yan Li. Consensus Guideline for the Management of Peritoneal Mesothelioma. Annals of Surgical Oncology 2026; 33(6) doi: 10.1245/s10434-025-17358-x
|
| 36 |
Hirokazu Saito, Shota Hasuda, Jiro Nasu, Mitsuhiko Kitaoka, Ikuo Matsushita. A case of malignant peritoneal mesothelioma suggesting the utility of combining double-contrast radiography and endoscopy with computed tomography for diagnosis. Clinical Journal of Gastroenterology 2017; 10(4) doi: 10.1007/s12328-017-0757-9
|
| 37 |
Jianting Ma, Shengzhi Zhang. Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02688-x
|
| 38 |
Annie Liu, Diana Cardona, Dan Blazer. Holland‐Frei Cancer Medicine. 2022; doi: 10.1002/9781119000822.hfcm095.pub2
|
| 39 |
Giorgio D’Annibale, Francesco Santullo, Lorenzo Barberis, Claudio Lodoli, Tommaso Partipilo, Giusi Giulia La Manna, Antonia Strippoli, Alexia Spring, Fabio Pacelli, Carlo Abatini. Navigating the Foggy Landscape of Epithelioid Peritoneal Mesothelioma: A Proposed Standardized Institutional Algorithm for Multimodal Management. Cancers 2026; 18(13) doi: 10.3390/cancers18132123
|
| 40 |
Amal Hajri, Kamal Benzidane, Fadoua Zalarh, Kenza Benjelloun Touimi, Anas El Wassi, Driss Erguibi, Rachid Boufettal, Saad Rifki Jai. Epithelioid Malignant Peritoneal Mesothelioma Revealed by Massive Ascites: A Case Report. Journal of Clinical Practice and Medical Research 2026; 2(2) doi: 10.59324/jcpmr.2026.2(2).14
|
| 41 |
Deepa Magge, Mazen S. Zenati, Frances Austin, Arun Mavanur, Magesh Sathaiah, Lekshmi Ramalingam, Heather Jones, Amer H. Zureikat, Matthew Holtzman, Steven Ahrendt, James Pingpank, Herbert J. Zeh, David L. Bartlett, Haroon A. Choudry. Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis. Annals of Surgical Oncology 2014; 21(4) doi: 10.1245/s10434-013-3358-y
|
| 42 |
Jennifer Faig, Suzanne Howard, Edward A. Levine, Gary Casselman, Mary Hesdorffer, Jill A. Ohar. Changing Pattern in Malignant Mesothelioma Survival. Translational Oncology 2015; 8(1) doi: 10.1016/j.tranon.2014.12.002
|
| 43 |
Yu‐Fei Liang, Guo‐Qi Zheng, Yue‐Feng Chen, Hui Song, Wen‐Jie Yin, Li Zhang. CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis. Journal of Gastroenterology and Hepatology 2016; 31(4) doi: 10.1111/jgh.13260
|
| 44 |
Rosa Alba Pugliesi, Federica Vernuccio, Cesare Maino, Francesco Matteini, Antonino Andrea Blandino, Giuseppe Brancatelli, Roberto Cannella. Lesions located at the liver periphery: A stepwise cross-sectional imaging approach toward diagnosis. European Journal of Radiology 2025; 190 doi: 10.1016/j.ejrad.2025.112208
|
| 45 |
Kazuhiro Kitajima, Kosuke Matsuda, Hiroyuki Yokoyama, Toshiyuki Minami, Akifumi Nakamura, Kozo Kuribayashi, Takashi Kijima, Koichiro Yamakado. Pretreatment volume-based 18F-FDG PET/CT parameters as prognostic indicators in malignant peritoneal mesothelioma patients. Japanese Journal of Radiology 2026; 44(7) doi: 10.1007/s11604-026-01977-9
|
| 46 |
Saoirse O. Dolly, Cristina Migali, Nina Tunariu, Chiara Della-Pepa, Shelize Khakoo, Steve Hazell, Johann S. de Bono, Stanley B. Kaye, Susana Banerjee. Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy. ESMO Open 2017; 2(1) doi: 10.1136/esmoopen-2016-000101
|
| 47 |
Amber R. Hitchcock. Sonographic Evaluation and Diagnosis of Peritoneal Mesothelioma Resulting in Massive Intra-abdominal Ascites. Journal of Diagnostic Medical Sonography 2015; 31(6) doi: 10.1177/8756479315611655
|
| 48 |
Shi Jin, Shoubo Cao, Jingyan Cao, Jing Shen, Jing Hu, Dehai Che, Jiawen Zhang, Yan Yu. Predictive Factors Analysis for Malignant Peritoneal Mesothelioma. Journal of Gastrointestinal Surgery 2015; 19(2) doi: 10.1007/s11605-014-2664-4
|
| 49 |
SEN HONG, MIAO-MIAO BI, PING-WEI ZHAO, XU WANG, QING-YANG KONG, YONG-TAO WANG, LEI WANG. Malignant peritoneal mesothelioma in a patient with intestinal fistula, incisional hernia and abdominal infection: A case report. Oncology Letters 2016; 11(3) doi: 10.3892/ol.2016.4203
|
| 50 |
Chih‐An Shih, Szu‐Pei Ho, Feng‐Woei Tsay, Kwok‐Hung Lai, Ping‐I Hsu. Diffuse malignant peritoneal mesothelioma. The Kaohsiung Journal of Medical Sciences 2013; 29(11) doi: 10.1016/j.kjms.2013.05.003
|
| 51 |
Anna K. Nowak, John G. Edwards, Jenette Creaney. Textbook of Uncommon Cancer. 2017; doi: 10.1002/9781119196235.ch16
|
| 52 |
Bryan B. Le, Ba D. Nguyen. Malignant Peritoneal Mesothelioma With Lower Extremity Metastasis. Clinical Nuclear Medicine 2015; 40(1) doi: 10.1097/RLU.0000000000000439
|
| 53 |
Krishna Pillai, Mohammad H. Pourgholami, Terence C. Chua, David L. Morris. MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma. The International Journal of Biological Markers 2013; 28(3) doi: 10.5301/JBM.5000038
|
| 54 |
Xiaohan Wang, RuiTing Liu, Chunli Wang, Jingjing Sun, Dongliang Yang. Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1480197
|
| 55 |
Susana Marques de Sousa, Filipa Pereira, Maria Duarte, Marta Marques, Dolores Vázquez, Cristina Marques. Malignant Peritoneal Mesothelioma as a Rare Cause of Dyspeptic Complaints and Ascites: A Diagnostic Challenge. GE - Portuguese Journal of Gastroenterology 2020; 27(3) doi: 10.1159/000503075
|
| 56 |
Yasuhiro Morita, Sadamu Sugiyama, Takeshi Tsuka, Yoshiharu Okamoto, Takehito Morita, Yuji Sunden, Takashi Takeuchi. Diagnostic efficacy of imaging and biopsy methods for peritoneal mesothelioma in a calf. BMC Veterinary Research 2019; 15(1) doi: 10.1186/s12917-019-2195-z
|